Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1

Detalles Bibliográficos
Autores principales: AL Assaf, Carla, Lierman, Els, Devos, Timothy, Billiet, Johan, Graux, Carlos, Papadopoulos, Petros, Vandenberghe, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199311/
https://www.ncbi.nlm.nih.gov/pubmed/24611479
http://dx.doi.org/10.1111/bjh.12790
_version_ 1782339887467331584
author AL Assaf, Carla
Lierman, Els
Devos, Timothy
Billiet, Johan
Graux, Carlos
Papadopoulos, Petros
Vandenberghe, Peter
author_facet AL Assaf, Carla
Lierman, Els
Devos, Timothy
Billiet, Johan
Graux, Carlos
Papadopoulos, Petros
Vandenberghe, Peter
author_sort AL Assaf, Carla
collection PubMed
description
format Online
Article
Text
id pubmed-4199311
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-41993112014-11-06 Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1 AL Assaf, Carla Lierman, Els Devos, Timothy Billiet, Johan Graux, Carlos Papadopoulos, Petros Vandenberghe, Peter Br J Haematol Correspondence BlackWell Publishing Ltd 2014-06 2014-02-26 /pmc/articles/PMC4199311/ /pubmed/24611479 http://dx.doi.org/10.1111/bjh.12790 Text en © 2014 The Authors. British Journal of Haematology published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Correspondence
AL Assaf, Carla
Lierman, Els
Devos, Timothy
Billiet, Johan
Graux, Carlos
Papadopoulos, Petros
Vandenberghe, Peter
Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
title Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
title_full Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
title_fullStr Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
title_full_unstemmed Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
title_short Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
title_sort screening of jak2 v617f and mpl w515 k/l negative essential thrombocythaemia patients for mutations in sesn2, dnajc17, st13, top1mt, and ntrk1
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199311/
https://www.ncbi.nlm.nih.gov/pubmed/24611479
http://dx.doi.org/10.1111/bjh.12790
work_keys_str_mv AT alassafcarla screeningofjak2v617fandmplw515klnegativeessentialthrombocythaemiapatientsformutationsinsesn2dnajc17st13top1mtandntrk1
AT liermanels screeningofjak2v617fandmplw515klnegativeessentialthrombocythaemiapatientsformutationsinsesn2dnajc17st13top1mtandntrk1
AT devostimothy screeningofjak2v617fandmplw515klnegativeessentialthrombocythaemiapatientsformutationsinsesn2dnajc17st13top1mtandntrk1
AT billietjohan screeningofjak2v617fandmplw515klnegativeessentialthrombocythaemiapatientsformutationsinsesn2dnajc17st13top1mtandntrk1
AT grauxcarlos screeningofjak2v617fandmplw515klnegativeessentialthrombocythaemiapatientsformutationsinsesn2dnajc17st13top1mtandntrk1
AT papadopoulospetros screeningofjak2v617fandmplw515klnegativeessentialthrombocythaemiapatientsformutationsinsesn2dnajc17st13top1mtandntrk1
AT vandenberghepeter screeningofjak2v617fandmplw515klnegativeessentialthrombocythaemiapatientsformutationsinsesn2dnajc17st13top1mtandntrk1

Ejemplares similares